+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Innovation Insights: Engineered Multispecific antibodies - Product Thumbnail Image

Innovation Insights: Engineered Multispecific antibodies

  • Report
  • December 2024
  • 53 Pages
  • Global
From
Alzheimer's Disease (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Alzheimer's Disease (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 49 Pages
  • Global
From
Glaucoma: Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Glaucoma: Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2024
  • 108 Pages
  • Global
From
Psoriatic Arthritis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Psoriatic Arthritis: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 43 Pages
  • Global
From
Atopic Dermatitis (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Atopic Dermatitis (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 34 Pages
  • Global
From
Gout: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Gout: Opportunity Assessment and Forecast - Update

  • Report
  • December 2024
  • 65 Pages
  • Global
From
Asthma and Severe Asthma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Asthma and Severe Asthma: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 70 Pages
  • Global
From
Schizophrenia: Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Schizophrenia: Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • November 2024
  • 134 Pages
  • Global
From
Sepsis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Sepsis: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 58 Pages
  • Global
From
Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • September 2024
  • 115 Pages
  • Global
From
Chronic Low Back Pain (CLBP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Low Back Pain (CLBP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 273 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 70 Pages
  • Global
From
Delirium - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Delirium - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 529 Pages
  • Global
From
Celiac Disease: Competitive Landscape - Product Thumbnail Image

Celiac Disease: Competitive Landscape

  • Report
  • August 2024
  • 63 Pages
  • Global
From
Epstein-Barr Virus: Competitive Landscape - Product Thumbnail Image

Epstein-Barr Virus: Competitive Landscape

  • Report
  • August 2024
  • 66 Pages
  • Global
From
Focal Segmental Glomerulosclerosis: Competitive Landscape - Product Thumbnail Image

Focal Segmental Glomerulosclerosis: Competitive Landscape

  • Report
  • August 2024
  • 76 Pages
  • Global
From
Acute coronary syndrome: Competitive Landscape - Product Thumbnail Image

Acute coronary syndrome: Competitive Landscape

  • Report
  • August 2024
  • 79 Pages
  • Global
From
Metachromatic Leukodystrophy (MLD) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Metachromatic Leukodystrophy (MLD) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • July 2024
  • 63 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more